US BROKER MOVES: LMND upgraded at Morgan Stanley; LLY downgraded at HSBC

• Adecoagro (AGRO) upgraded from Underweight to Equalweight at Morgan Stanley; PT USD 13.00 (prev. USD 9.50)
• Align Technology (ALGN) upgraded from Equalweight to Overweight at Barclays; PT USD 200.00
• Canadian Solar (CSIQ) upgraded from Underperform to Neutral at Mizuho; PT USD 19.00 (prev. USD 21.00)
• Dover (DOV) upgraded from Equal Weight to Overweight at Wells Fargo; PT USD 230.00 (prev. USD 210.00)
• Essential Properties Realty Trust (EPRT) upgraded from Outperform to Strong Buy at Raymond James; PT USD 37.00 (prev. USD 35.00)
• Ichor Holdings (ICHR) upgraded from Hold to Buy at Stifel; PT USD 55.00 (prev. USD 30.00)
• Lifecore Biomedical (LFCR) upgraded from Market Perform to Outperform at Barrington Research; PT USD 5.50
• Lemonade (LMND) upgraded from Equalweight to Overweight at Morgan Stanley; PT USD 85.00 (prev. USD 80.00)
• LATAM Airlines (LTM) upgraded from Neutral to Buy at Citi; PT USD 58.00 (prev. USD 53.00)
• MSCI (MSCI) upgraded from Outperform to Strong Buy at Raymond James; PT USD 710.00
• National Storage Affiliates (NSA) upgraded from Underperform to In Line at Evercore ISI; PT USD 41.00 (prev. USD 33.00)
• Alpine Income Property Trust (PINE) upgraded from Outperform to Strong Buy at Raymond James; PT USD 22.00
• Target Hospitality (TH) upgraded from Perform to Outperform at Oppenheimer; PT USD 11.00
• Tandem Diabetes Care (TNDM) upgraded from Neutral to Overweight at Piper Sandler; PT USD 33.00 (prev. USD 21.00)
• W. P. Carey (WPC) upgraded from Market Perform to Outperform at Raymond James; PT USD 76.00

• CONMED (CNMD) downgraded from Overweight to Neutral at Piper Sandler; PT USD 39.00 (prev. USD 55.00)
• DraftKings (DKNG) downgraded from Buy to Hold at Argus
• EPR Properties (EPR) downgraded from Strong Buy to Outperform at Raymond James; PT USD 60.00 (prev. USD 62.00)
• Li Auto (LI) downgraded from Buy to Neutral at Goldman Sachs; PT USD 19.00 (prev. USD 23.00)
• Eli Lilly (LLY) downgraded from Hold to Reduce at HSBC; PT USD 850.00 (prev. USD 1,070.00)
• MarketAxess (MKTX) downgraded from Buy to Hold at Argus
• PlayStudios (MYPS) downgraded from Speculative Buy to Hold at Benchmark
• NNN REIT (NNN) downgraded from Outperform to Market Perform at Raymond James
• NetSTREIT (NTST) downgraded from Strong Buy to Outperform at Raymond James; PT USD 22.00 (prev. USD 21.00)
• Sony (SONY) downgraded from Outperform to Market Perform at Bernstein SocGen; PT USD 22.00 (prev. USD 30.00)

• Arthur J. Gallagher (AJG) initiated at Outperform at RBC Capital; PT USD 260.00
• Brown & Brown (BRO) initiated at Sector Perform at RBC Capital; PT USD 76.00
• Goosehead Insurance (GSHD) initiated at Sector Perform at RBC Capital; PT USD 49.00
• Ingredion (INGR) initiated at Buy at Benchmark
• Nektar Therapeutics (NKTR) initiated at Buy at TD Cowen
• Ocugen (OCGN) initiated at Buy at Canaccord; PT USD 12.00
• PTC Inc. (PTC) initiated at Overweight at Barclays; PT USD 180.00
• QuinStreet (QNST) initiated at Outperform at Northland
• Ryan Specialty (RYAN) initiated at Outperform at RBC Capital; PT USD 45.00
• Tenax Therapeutics (TENX) initiated at Overweight at Cantor Fitzgerald; PT USD 35.00
• TIC Solutions (TIC) initiated at Buy at Roth/MKM; PT USD 10.00
• Zentalis Pharmaceuticals (ZNTL) initiated at Equal Weight at Wells Fargo; PT USD 5.00

Today's upgrades and downgrades reflect a significant shift in market sentiment, particularly in the healthcare sector with Eli Lilly's downgrade potentially indicating growing concerns about its growth trajectory. On the flip side, upgrades for companies like Lemonade suggest increased analyst confidence, which could drive positive sentiment in those stocks. Overall, these changes could impact sector dynamics and influence trading strategies based on anticipated shifts in investor interest and stock performance.